Search Within

Ronald D Finn

Formats
  1. Journal Article (137)
  2. Meeting Abstract (128)
  3. Conference Paper (13)
  4. Book Section (1)
Groups
  1. GSK Faculty (243)
  2. Molecular Pharmacology and Chemistry Program Faculty (243)
  3. Sloan Kettering Institute Faculty (243)
  4. Radiology, Department of (223)
  5. Molecular Imaging and Therapy Service (189)
  6. Department of Medicine (109)

More Groups

People
  1. Steven Larson (184)
  2. Ronald Blasberg (73)
  3. Juri Gelovani (61)
  4. John Humm (56)
  5. Chaitanya Divgi (54)
  6. David Scheinberg (52)

More People

Years
  1. 2019 (2)
  2. 2012 (1)
  3. 2010 (1)
  4. 2008 (1)
  5. 2007 (7)
  6. 2006 (11)

More Years

Publications
  1. Journal of Nuclear Medicine (99)
  2. Nuclear Medicine and Biology (11)
  3. Journal of Clinical Oncology (10)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (10)
  5. Blood (9)
  6. Cancer Research (9)

More Publications

Publishers
  1. Society of Nuclear Medicine (99)
  2. American Association for Cancer Research (26)
  3. Elsevier Inc. (14)
  4. Elsevier Science Inc. (14)
  5. Wiley Blackwell (14)
  6. Nature Publishing Group (13)

More Publishers

Results (279)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody I-131-CC49
    Journal Article

    Kostakoglu, L.; Divgi, C. R.; Hilton, S.; Cordon-Cardo, C.; Scott, A. M.; Kalaigian, H.; Finn, R. D.; Schlom, J.; Larson, S. M.
    Cancer Investigation (1994)

    Fulltext@MSK | Save
  • Murine and humanized constructs of monoclonal antibody M195 (anti‐CD33) for the therapy of acute myelogenous leukemia
    Conference Paper

    Caron, P. C.; Schwartz, M. A.; Co, M. S.; Queen, C.; Finn, R. D.; Graham, M. C.; Divgi, C. R.; Larson, S. M.; Scheinberg, D. A.
    Wiley Blackwell (1994)

    Fulltext@MSK | Save
  • A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: Specific targeting without immunogenicity
    Journal Article

    Caron, P. C.; Jurcic, J. G.; Scott, A. M.; Finn, R. D.; Divgi, C. R.; Graham, M. C.; Jureidini, I. M.; Sgouros, G.; Tyson, D.; Old, L. J.; more...
    Blood (1994)

    Fulltext@MSK | Save
  • Clinical comparison of radiolocalization of 2 anti-tag-72 monoclonal-antibodies (MABS)
    Meeting Abstract

    Divgi, C. R.; Scott, A. M.; McDermott, K.; Fallone, P. S.; Carmichael, N.; Hilton, S.; Siler, K.; Finn, R. D.; Daghighian, F.; Cohen, A. M.; more...
    Journal of Nuclear Medicine (1993)

    Fulltext@MSK | Save
  • Improving the purity of [F-18]2FDG preparations
    Meeting Abstract

    Johnson, B. F.; Sabourin, C. L.; Finn, R. D.
    Journal of Nuclear Medicine (1993)

    Fulltext@MSK | Save
  • Quantitation of P-glycoprotein receptor expression in vivo with I-125 MRK-16 monoclonal antibody (MAB)
    Meeting Abstract

    Scott, A. M.; Rosa, E.; Carmichael, N.; Finn, R. D.; Divgi, C. R.; Biedler, J. L.; Tsuruo, T.; Mehta, B. M.; Kalaigian, H.; Larson, S. M.
    Journal of Nuclear Medicine (1993)

    Fulltext@MSK | Save
  • Radioimmunoscintigraphy (RIS) of hepatic metastases from colorectal carcinoma (CRC) using I-131-labeled monoclonal antibody (MAB) F19
    Meeting Abstract

    Divgi, C. R.; Welt, S.; Rettig, W.; Scott, A. M.; Garin-Chesa, P.; Carmichael, N.; Fallone, P. S.; Finn, R. D.; Cohen, A. M.; Old, L. J.; more...
    Journal of Nuclear Medicine (1993)

    Fulltext@MSK | Save
  • Clinical implementation of modeling-based radioimmunotherapy treatment planning: I-131-M195 antibody against chronic myelogenous leukemia
    Meeting Abstract

    Sgouros, G.; Graham, M. C.; Scott, A.; Caron, P. C.; Divgi, C. R.; Finn, R.; Carabasi, M.; Larson, S. M.; Scheinberg, D. A.
    Journal of Nuclear Medicine (1993)

    Fulltext@MSK | Save
  • Assessment of brain tumor proliferative activity using I-131 iododeoxyuridine (IUDR)
    Meeting Abstract

    Macapinlac, H.; Scott, A.; Daghighian, F.; Yeh, S.; Ginos, J.; Tjuvajev, J.; Zhang, J.; Finn, R.; Larson, S.; Blasberg, R.
    Journal of Nuclear Medicine (1993)

    Fulltext@MSK | Save
  • I-131 M195 (anti-CD33) radioimmunotherapy trials in patients with myeloid leukemias
    Meeting Abstract

    Larson, S. M.; Scott, A. M.; Divgi, C. R.; Finn, R. D.; Graham, M. C.; Sgouros, G.; Scheinberg, D. A.
    Journal of Nuclear Medicine (1993)

    Fulltext@MSK | Save